High doses of OP-1 inhibit fibrous tissue ingrowth in impaction grafting

Clinical Orthopaedics and Related Research

Volumn 452, Issue , 2006, Pages 250-259

  Hannink, Gerjon ^a   Aspenberg, Per ^b   Schreurs, B Willem ^a   Buma, Pieter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; HYDROXYAPATITE; OSTEOGENIC PROTEIN 1; BMP7 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN; CERATITE;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GRAFT; BONE IMPACTION GRAFT; BONE REMODELING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; GOAT; HOST; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; ANIMAL; BONE DEVELOPMENT; BONE TRANSPLANTATION;

ANIMALS; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; CALCIUM PHOSPHATES; GOATS; HYDROXYAPATITES;

EID: 33750623985     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000229340.18974.dc     Document Type: Article

References (55)

1. Allan DG, Lavoie GJ, McDonald S, Oakeshott R, Gross AE. Proximal femoral allografts in revision hip arthroplasty. J Bone Joint Surg Br. 1991;73:235-240.
2. Arm DM, Tencer AF, Bain SD, Celino D. Effect of controlled release of platelet-derived growth factor from a porous hydroxyapatite implant on bone ingrowth. Biomaterials. 1996;17:703-709.
3. Aspenberg P, Astrand J. Bone allografts pretreated with a bisphosphonate are not resorbed. Acta Orthop Scand. 2002;73:20-23.
4. Aspenberg P, Wang JS. A new bone chamber used for measuring osteoconduction in rats. Eur J Exp Musculoskel Res. 1993;2:69-74.
5. Astrand J, Aspenberg P. Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats. Acta Orthop Scand. 2002;73:24-30.
6. Bolder SB, Verdonschot N, Schreurs BW, Buma P. Acetabular defect reconstruction with impacted morsellized bone grafts or TCP/HA particles: a study on the mechanical stability of cemented cups in an artificial acetabulum model. Biomaterials. 2002;23:659-666.
7. Bostrom M, Lane JM, Tomin E, Browne M, Berberian W, Turek T, Smith J, Wozney J, Schildhauer T. Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop Relat Res. 1996;327:272-282.
8. Bostrom MP, Aspenberg P, Jeppsson C, Salvati EA. Enhancement of bone formation in the setting of repeated tissue deformation. Clin Orthop Relat Res. 1998;350:221-228.
9. Buma P, Lamerigts N, Schreurs BW, Gardeniers J, Versleyen D, Slooff TJ. Impacted graft incorporation after cemented acetabular revision: histological evaluation in 8 patients. Acta Orthop Scand. 1996;67:536-540.
10. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop Relat Res. 1994;301:302-312.
11. Cook SD, Barrack RL, Santman M, Patron LP, Salkeld SL, Whitecloud TS. The Otto Aufranc Award: Strut allograft healing to the femur with recombinant human osteogenic protein-1. Clin Orthop Relat Res. 2000;381:47-57.
12. Cook SD, Barrack RL, Shimmin A, Morgan D, Carvajal JP. The use of osteogenic protein-1 in reconstructive surgery of the hip. J Arthroplasty. 2001;16:88-94.
13. Cook SD, Salkeld SL, Patron LP, Sargent MC, Rueger DC. Healing course of primate ulna segmental defects treated with osteogenic protein-1. J Invest Surg. 2002;15:69-79.
14. Fischgrund JS, James SB, Chabot MC, Hankin R, Herkowitz HN, Wozney JM, Shirkhoda A. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. J Spinal Disord. 1997;10:467-472.
15. Franke Stenport V, Johansson C, Joo Heo S, Albrektsson T. Titanium implants and BMP-7 in bone: an experimental model in the rabbit. J Mater Sci Mater Med. 2003;14:247-254.
16. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83(suppl 1):S151-S158.
17. Frost HM. The biology of fracture healing: An overview for clinicians. Part I. Clin Orthop Relat Res. 1989;248:283-293.
18. Fujishiro T, Nishikawa T, Niikura T, Takikawa S, Nishiyama T, Mizuno K, Yoshiya S, Kurosaka M. Impaction bone grafting with hydroxyapatite: increased femoral component stability in experiments using Sawbones. Acta Orthop. 2005;76:550-554.
19. Gatti AM, Zaffe D, Poli GP. Behaviour of tricalcium phosphate and hydroxyapatite granules in sheep bone defects. Biomaterials. 1990;11:513-517.
20. Gie GA, Linder L, Ling RS, Simon JP, Slooff TJ, Timperley AJ. Impacted cancellous allografts and cement for revision total hip arthroplasty. J Bone Joint Surg Br. 1993;75:14-21.
21. Halliday BR, English HW, Timperley AJ, Gie GA, Ling RSM. Femoral impaction grafting with cement in revision total hip replacement: evolution of the technique and results. J Bone Joint Surg Br. 2003;85:809-817.
22. Heekin RD, Engh CA, Vinh T. Morselized allograft in acetabular reconstruction: a postmortem retrieval analysis. Clin Orthop Relat Res. 1995;319:184-190.
23. Hentunen TA, Lakkakorpi PT, Tuukkanen J, Lehenkari PP, Sampath TK, Vaananen HK. Effects of recombinant human osteogenic protein-1 on the differentiation of osteoclast-like cells and bone resorption. Biochem Biophys Res Commun. 1995;209:433-443.
24. Jensen TB, Overgaard S, Lind M, Rahbek O, Bunger C, Soballe K. Osteogenic protein 1 device increases bone formation and bone graft resorption around cementless implants. Acta Orthop Scand. 2002;73:31-39.
25. Jeppsson C, Aspenberg P. BMP-2 can inhibit bone healing: bone-chamber study in rabbits. Acta Orthop Scand. 1996;67:589-592.
26. Kanatani M, Sugimoto T, Kaji H, Kobayashi T, Nishiyama K, Fukase M, Kumegawa M, Chihara K. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res. 1995;10:1681-1690.
27. Kaneko H, Arakawa T, Mano H, Kaneda T, Ogasawara A, Nakagawa M, Toyama Y, Yabe Y, Kumegawa M, Hakeda Y. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone. 2000;27:479-486.
28. Laursen M, Hoy K, Hansen ES, Gelineck J, Christensen FB, Bunger CE. Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary results. Eur Spine J. 1999;8:485-490.
29. Lind M, Overgaard S, Jensen TB, Song Y, Goodman SB, Bunger C, Soballe K. Effect of osteogenic protein 1/collagen composite combined with impacted allograft around hydroxyapatite-coated titanium alloy implants is moderate. J Biomed Mater Res. 2001;55:89-95.
30. Lind M, Overgaard S, Song Y, Goodman SB, Bunger C, Soballe K. Osteogenic protein 1 device stimulates bone healing to hydroxyapaptite-coated and titanium implants. J Arthroplasty. 2000;15:339-346.
31. Linder L. Cancellous impaction grafting in the human femur: histological and radiographic observations in 6 autopsy femurs and 8 biopsies. Acta Orthop Scand. 2000;71:543-552.
32. Malchau H, Herberts P, Ahnfelt L. Prognosis of total hip replacement in Sweden: follow-up of 92,675 operations performed 1978-1990. Acta Orthop Scand. 1993;64:497-506.
33. McGee MA, Findlay DM, Howie DW, Carbone A, Ward P, Stamenkov R, Page TT, Bruce WJ, Wildenauer CI, Toth C. The use of OP-1 in femoral impaction grafting in a sheep model. J Orthop Res. 2004;22:1008-1015.
34. Oonishi H. Orthopaedic applications of hydroxyapatite. Biomaterials. 1991;12:171-178.
35. Oonishi H, Iwaki Y, Kin N, Kushitani S, Murata N, Wakitani S, Imoto K. Hydroxyapatite in revision of total hip replacements with massive acetabular defects: 4- to 10-year clinical results. J Bone Joint Surg Br. 1997;79:87-92.
36. Pratt JN, Griffon DJ, Dunlop DG, Smith N, Howie CR. Impaction grafting with morsellised allograft and tricalcium phosphate-hydroxyapatite: incorporation within ovine metaphyseal bone defects. Biomaterials. 2002;23:3309-3317.
37. Ripamonti U, Crooks J, Matsaba T, Tasker J. Induction of endochondral bone formation by recombinant human transforming growth factor-beta 2 in the baboon (Papio ursinus). Growth Factors. 2000;17:269-285.
38. Salcetti JM, Moriarty JD, Cooper LF, Smith FW, Collins JG, Socransky SS, Offenbacher S. The clinical, microbial, and host response characteristics of the failing implant. Int J Oral Maxillofac Implants. 1997;12:32-42.
39. Salkeld SL, Patron LP, Barrack RL, Cook SD. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am. 2001;83:803-816.
40. Schreurs BW, Bolder SB, Gardeniers JW, Verdonschot N, Slooff TJ, Veth RP. Acetabular revision with impacted morsellised cancellous bone grafting and a cemented cup: a 15- to 20-year follow-up. J Bone Joint Surg Br. 2004;86:492-497.
41. Schreurs BW, Huiskes R, Buma P, Slooff TJ. Biomechanical and histological evaluation of a hydroxyapatite-coated titanium femoral stem fixed with an intramedullary morsellized bone grafting technique: an animal experiment on goats. Biomaterials. 1996;17:1177-1186.
42. Soballe K, Jensen TB, Mouzin O, Kidder L, Bechtold JE. Differential effect of a bone morphogenetic protein-7 (OP-1) on primary and revision loaded, stable implants with allograft. J Biomed Mater Res A. 2004;71:569-576.
43. Tägil M. The morselized and impacted bone graft: animal experiments on proteins, impaction and load. Acta Orthop Scand Suppl. 2000;290:1-40.
44. Tägil M, Aspenberg P. Impaction of cancellous bone grafts impairs osteoconduction in titanium chambers. Clin Orthop Relat Res. 1998;352:231-238.
45. Tägil M, Aspenberg P. Fibrous tissue armoring increases the mechanical strength of an impacted bone graft. Acta Orthop Scand. 2001;72:78-82.
46. Tägil M, Jeppsson C, Aspenberg P. Bone graft incorporation: effects of osteogenic protein-1 and impaction. Clin Orthop Relat Res. 2000;371:240-245.
47. Tägil M, Jeppsson C, Wang JS, Aspenberg P. No augmentation of morselized and impacted bone graft by OP-1 in a weight-bearing model. Acta Orthop Scand. 2003;74:742-748.
48. Takita H, Vehof JW, Jansen JA, Yamamoto M, Tabata Y, Tamura M, Kuboki Y. Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats. J Biomed Mater Res A. 2004;71:181-189.
49. Toms AD, Barker RL, Jones RS, Kuiper JH. Impaction bone-grafting in revision joint replacement surgery. J Bone Joint Surg Am. 2004;86:2050-2060.
50. Van Der Donk S, Buma P, Aspenberg P, Schreurs BW. Similarity of bone ingrowth in rats and goats: a bone chamber study. Comp Med. 2001;51:336-340.
51. Van Der Donk S, Buma P, Slooff TJ, Gardeniers JW, Schreurs BW. Incorporation of morselized bone grafts: a study of 24 acetabular biopsy specimens. Clin Orthop Relat Res. 2002;396:131-141.
52. Van Der Donk S, Weernink T, Buma P, Aspenberg P, Slooff TJ, Schreurs BW. Rinsing morselized allografts improves bone and tissue ingrowth. Clin Orthop Relat Res. 2003;408:302-310.
53. Verdonschot N, van Hal CT, Schreurs BW, Buma P, Huiskes R, Slooff TJ. Time-dependent mechanical properties of HA/TCP particles in relation to morsellized bone grafts for use in impaction grafting. J Biomed Mater Res. 2001;58:599-604.
54. Wang JS. Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or conductive implants. Acta Orthop Scand Suppl. 1996;269:1-33.
55. Xu JW, Konttinen YT, Li TF, Waris V, Lassus J, Matucci-Cerinic M, Sorsa T, Santavirta TS. Production of platelet-derived growth factor in aseptic loosening of total hip replacement. Rheumatol Int. 1998;17:215-221.